Armata Pharmaceuticals Announces Presentation of Topline Data From SWARM-P.a. Clinical Study Of AP-PA02 For Chronic Pulmonary Pseudomonas Aeruginosa Infections In Cystic Fibrosis Patients At North American Cystic Fibrosis Conference
Armata Pharmicals 宣佈公佈來自 Swarm-p.A. 的頭條數據在北美囊性纖維化會議上對囊性纖維化患者慢性肺銅綠假單胞菌感染 AP-PA02 的臨床研究